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Background: Host and viral proteins are involved in dengue virus (DENV) replication. Heterogeneous
ribonucleoprotein (hnRNP) C1/C2 are abundant host cellular proteins that exhibit RNA binding activity and play
important roles in the replication of positive-strand RNA viruses such as poliovirus and hepatitis C virus. hnRNP C1/C2
have previously been shown to interact with vimentin and viral NS1 in DENV-infected cells; however, their functional
role in DENV replication is not clearly understood. In the present study, we investigated the role of hnRNP C1/C2 in
DENV replication by using an in vitro model of DENV infection in a hepatocyte cell line (Huh7) and siRNA-mediated
knockdown of hnRNP C1/C2.
Methods: Huh7 cells were transfected with hnRNP C1/C2-specific siRNA or irrelevant siRNA (control) followed by
infection with DENV. Mock and DENV-infected knockdown cells were processed for immunoprecipitation using hnRNP
C1/C2-specific antibody or their isotype-matched control antibody. The immunoprecipitated samples were subjected
to RNA extraction and reverse transcriptase polymerase chain reaction (RT-PCR) for detection of DENV RNA. In addition,
the knockdown cells harvested at varying time points after the infection were assessed for cell viability, cell proliferation,
percentage of DENV infection, amount of viral RNA, and viral E and NS1 expression. Culture supernatants were
subjected to focus forming unit assays to determine titers of infectious DENV. DENV luciferase reporter assay was
also set up to determine viral translation.
Results: Immunoprecipitation with the anti-hnRNP C1/C2 antibody and subsequent RT-PCR revealed the presence
of DENV RNA in the immunoprecipitated complex containing hnRNP C1/C2 proteins. Transfection with hnRNP
C1/C2-specific siRNA resulted in a significant reduction of hnRNP C1/C2 mRNA and protein levels but did not induce
cell death during DENV infection. The reduced hnRNP C1/C2 expression decreased the percentage of DENV
antigen-positive cells as well as the amount of DENV RNA and the relative levels of DENV E and NS1 proteins;
however, it had no direct effect on DENV translation. In addition, a significant reduction of DENV titers was observed in
the supernatant from DENV-infected cells following the knockdown of hnRNP C1/C2.
Conclusions: Our findings suggest that hnRNP C1/C2 is involved in DENV replication at the stage of viral RNA synthesis.
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Figure 1 Association of hnRNP C1/C2 proteins with dengue
viral RNA. Mock-infected (M) and DENV-infected (I) cells were
subjected to immunoprecipitation using anti-hnRNPC1/C2 (αhnRNP
C) monoclonal antibody and their isotype-matched control antibody
(IgG1). (A) Immunoprecipitated proteins were analyzed by
immunoblotting using hnRNP C1/C2-specific antibody. Mock and
DENV-infected cell lysates prior to immunoprecipitation served as
controls (input). (B) RNA was extracted from the immunoprecipitated
samples and used as a template for RT-PCR with a primer pair specific
for DENV NS1 region. PCRs performed in parallel in the absence of
cDNA and in the presence of pcDNAhygro containing DENV NS1 gene
were included as negative (−) and positive (+) controls, respectively.
Results are representative of three independent experiments with
similar outcome.
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Dengue virus (DENV) infection poses a major public
health threat that affects over 40% of the world’s popu-
lation [1]. Infection with any of four serotypes of DENV
(i) can be asymptomatic; (ii) cause a self-limiting, mild
febrile illness known as dengue fever; or (iii) cause life-
threatening illnesses called dengue hemorrhagic fever
(DHF) and dengue shock syndrome (DSS) [2,3]. At
present, the mechanism of DENV infection that leads to
pathogenesis of DHF/DSS remains unclear.
DENV is a member of the flaviviruses in the family
Flaviviridae. It is a positive-sense, single-stranded, envel-
oped RNA virus that has previously been reported to enter
different types of host cells, for example, dendritic cells,
monocytes, endothelial cells and hepatocytes, through
receptor-dependent mechanisms or antibody-dependent
enhancement [4-7]. DENV polyprotein is encoded by
the positive-strand viral RNA genome and processed in
DENV-infected cells by viral and cellular proteases to gen-
erate three structural proteins (capsid, C; pre-membrane,
prM; and envelope, E) and seven nonstructural proteins
(NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) [8,9]. In-
teractions of these viral proteins with several host cellular
proteins play important roles in the entry, replication, as-
sembly and egress of DENV, as well as cell signaling and
immune escape from host responses during DENV infec-
tion, as reported previously [10-13].
hnRNP C1/C2 are abundant host cellular proteins
among at least 20 members (hnRNP A-U) of the hnRNP
family [14,15] that share common characteristics, but still
possess a variety of domain compositions and functional
properties. hnRNP C1/C2 differ by 13-amino acid residues
after glycine 106 or serine 107 as a result of alternative
mRNA splicing, and the longer isoform (C2) comprises
~25% of the total hnRNP C in the cells [16,17]. Both the
hnRNP C isoforms contain an RNA recognition motif and
a basic leucine zipper-like RNA-binding motif that bind
RNA in the form of heterotetramers with three molecules
of C1 and one molecule of C2 [18,19]. hnRNP C1/C2 are
involved in mRNA biogenesis, transport and stability, as
well as protein translation [14,15]. Normally, hnRNP C1/C2
reside mainly in the nucleus [20]. However, certain cellular
conditions (e.g., apoptosis, mitosis and virus infection) in-
duce hnRNP C1/C2 to translocate from the nucleus to the
cytoplasm [21-25]. hnRNP C1/C2 were previously identi-
fied as DENV NS1-interacting host partners but the role
of their association remained undefined [26]. Additionally,
hnRNP C1/C2 have been found to interact with vimentin,
an intermediate filament supporting cell integrity, which
is recruited to the perinuclear region with dense structural
rearrangement during DENV infection, and is necessary
for the infection process [27-29].
To explore the potential involvement of hnRNP C1/C2
in DENV replication, we employed an in vitro study usingthe hepatocyte Huh7 cell line for DENV infection and
specific siRNA-mediated gene knockdown. Effects of
hnRNP C1/C2 knockdown on different events in DENV
infection and replication have been investigated.
Results
Association of hnRNP C1/C2 proteins with DENV RNA
To address a possibility that hnRNP C1/C2, RNA-binding
proteins, might associate with viral RNA in DENV-
infected cells, immunoprecipitation of mock-infected and
DENV-infected cell lysates was performed using anti-
hnRNP C1/C2 specific antibody or its isotype-matched
control antibody. Immunoprecipitated samples were
assayed for the presence of hnRNP C1/C2 proteins by
immunoblotting analysis and also subjected to RNA
extraction and subsequent RT-PCR for detection of
DENV NS1 amplicon. Prior to immunoprecipitation, im-
munoblotting analysis demonstrated that hnRNP C1/C2
were present in mock-infected and DENV-infected cell
lysates (Figure 1A, Input: M and I). Immunoprecipita-
tion with anti-hnRNP C1/C2 antibody allowed for en-
richment of hnRNP C1/C2 proteins in mock-infected
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and I), while no specific protein band was discernible
following immunoprecipitation with isotype-matched
control antibody (Figure 1A, IgG1: M and I). Further
analysis by RT-PCR revealed that an amplicon band
corresponding to DENV NS1 region was detected in
DENV-infected samples immunoprecipitated with
anti-hnRNP C1/C2 antibody (Figure 1B, αhnRNP C: I).
Mock-infected samples immunoprecipitated with the same
antibody did not yield any amplicon band (Figure 1B,
αhnRNP C: M). In addition, no specific band was evident
in mock-infected and DENV-infected samples immunopre-
cipitated with isotype-matched control antibody (Figure 1B,
IgG1: M and I). The results indicated the specific detection
of viral RNA in the context of hnRNP C1/C2 complexes
in DENV-infected cells.
Knockdown of hnRNP C1/C2 by specific siRNA
transfection
Whether hnRNP C1/C2 proteins associating with viral
RNA are involved in the DENV infection process was
addressed using siRNA transfection to knockdown
hnRNP C1/C2 prior to DENV infection. Initially, we
tested the effect of siRNA transfection on hnRNP C1/C2
mRNA expression. Huh7 cells were transfected with ei-
ther hnRNP C1/C2-specific siRNA or irrelevant control
siRNA and subsequently infected with DENV. The cells
were harvested post-infection to determine the expres-
sion of hnRNP C1/C2 and β-actin (internal control)
mRNA using real time RT-PCR. Relative levels of
hnRNP C1/C2 mRNA expression was significantly de-
creased by approximately 60–70% in hnRNP C1/C2
siRNA-transfected cells compared with control cells at
all time points tested (Figure 2A). This indicated the effi-
ciency of hnRNP C1/C2 mRNA knockdown during
DENV infection.
To confirm whether levels of hnRNP C1/C2 proteins
are reduced following specific siRNA transfection, unin-
fected cells (mock control) or DENV-infected cells that
had been transfected with either hnRNP C1/C2-specific
siRNA or irrelevant control siRNA were subjected to im-
munoblotting analysis using specific antibody against
hnRNP C1/C2 and β-actin proteins. Immunoblotting
showed that transfection with hnRNP C1/C2-specific
siRNA resulted in decreased expression of hnRNP C1/
C2 protein bands in mock-infected and DENV-infected
cells compared with control siRNA transfection. Equiva-
lent expression of β-actin protein bands (internal con-
trol) was observed in the same set of samples following
transfection with either siRNA (Figure 2B, top panel).
Normalization of hnRNP C1/C2 to β-actin protein dem-
onstrated that relative expression of hnRNP C1/C2 pro-
teins was reduced by 40–60% during the whole study
period in both mock-infected and DENV-infected cellstransfected with hnRNP C1/C2-specific siRNA com-
pared with control siRNA-transfected cells (Figure 2B,
bottom panel). This hnRNP C1/C2 knockdown effect
could still be observed even at 48 h post-infection
(Figure 2B).
Effects of hnRNP C1/C2 knockdown on cell viability and
proliferation
To determine whether knockdown of hnRNP C1/C2
proteins affects cell viability and proliferation, mock-
infected and DENV-infected cells that had been trans-
fected with hnRNP C1/C2-specific siRNA or irrelevant
control siRNA were assessed for the percentage of cell
viability and the total cell number at varying time points
post infection as described in the Materials and
Methods. Mock-infected and DENV-infected knock-
down cells transfected with either siRNA showed similar
percentages of cell viability ranging from 90% to 97%
within 48 h of the study period (Figure 3A and B). This
suggested that knockdown of hnRNP C1/C2 proteins did
not induce cell death following DENV infection (Figure 3A
and B). Regardless of the type of siRNA used for trans-
fection, both mock-infected and DENV-infected knock-
down cells increased over time with the same kinetic
pattern of proliferation during 36 h post infection
(Figure 3C and D). Although the total number of mock-
infected and DENV-infected cells, which had been trans-
fected with hnRNP C1/C2-specific siRNA, seemed to be
relatively lower than that transfected with control siRNA
at 48 h post infection, no statistically significant difference
in cell proliferation was observed at this time point
(Figure 3C and D). Thus, knockdown of hnRNP C1/C2
proteins had no profound effect on proliferation of mock-
infected and DENV-infected cells within the study period
tested.
Effects of hnRNP C1/C2 knockdown on DENV RNA and
protein syntheses
To investigate possible effects of hnRNP C1/C2 knock-
down on specific events in DENV replication, control
and hnRNP C1/C2 siRNA-transfected cells were infected
with DENV and harvested after infection to determine
levels of DENV E RNA, the percentage of DENV infec-
tion and levels of DENV NS1 and E proteins, using real-
time RT-PCR, immunofluorescence staining and im-
munoblotting analysis, respectively. Real-time RT-PCR
demonstrated that DENV RNA was detected in control
and hnRNP C1/C2 siRNA-transfected cells in a time-
dependent manner following DENV infection (Figure 4).
The levels of DENV RNA in the control siRNA-
transfected cells rapidly increased and peaked within
36 h post-infection. However, the kinetics of DENV
RNA appeared to be delayed in hnRNP C1/C2 siRNA-
transfected cells and its expression was lower than that
Figure 2 (See legend on next page.)
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Figure 2 siRNA-mediated knockdown of hnRNP C1/C2 mRNA and proteins. (A) Huh7 cells transfected with hnRNP C1/C2-specific or control
siRNA were infected with DENV at MOI 0.03. Cells were collected at 0, 12, 24, 36 and 48 h post-infection and subjected to total RNA extraction
and subsequent reverse transcription and real-time PCR for determination of hnRNP C1/C2 and β-actin (internal control) mRNA expression.
Relative hnRNP C1/C2 mRNA expression was obtained by normalization with β-actin mRNA expression in siRNA-transfected cells following DENV
infection. Fold change of the relative hnRNP C1/C2 mRNA expression between the specific siRNA and control siRNA-transfected samples was
compared. Data represent mean and SEM of three independent experiments. Asterisks indicate statistically significant differences (*p < 0.05; **p < 0.01)
in hnRNP C1/C2 levels between the specific siRNA-transfected and control siRNA-transfected groups by unpaired t test. (B) Huh7 cells were transfected
with hnRNP C1/C2-specific siRNA (SP) or irrelevant negative control siRNA (IR), followed by mock or DENV infection at MOI 0.03. Cells were collected at
the indicated time points post-infection and subjected to immunoblotting analysis using monoclonal antibodies specific against human hnRNP C1/C2
and β-actin (internal protein control). Immunoblotting analysis of hnRNP C1/C2 and β-actin proteins in mock-infected and DENV-infected cells was shown
as representative of three independent experiments (top panel). The intensity of hnRNP C1/C2 bands in both IR and SP samples was first normalized to
that of β-actin in the same set of samples. The obtained relative intensity of hnRNP C1/C2 in the SP samples was then normalized to that in the IR samples.
Results show fold change of relative hnRNP C1/C2 protein expression in the SP samples compared with the corresponding IR samples (bottom panel). Data
represent mean and SEM of three independent experiments. Asterisks indicate statistically significant differences (*p < 0.05; **p < 0.01) in relative expression
of hnRNP C1/C2 proteins between the specific siRNA-transfected and control siRNA-transfected samples by unpaired t test.
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36 h post-infection, there was an approximately six-fold
difference in DENV RNA levels between the control and
hnRNP C1/C2 siRNA-transfected cells. Although a sta-
tistically significant difference in DENV RNA levels be-
tween the control and hnRNP C1/C2 siRNA-transfected
cells was not observed at every time point tested, a ten-
dency of reducing DENV RNA levels following specific
siRNA transfection suggested the interference of hnRNP
C1/C2 knockdown on DENV RNA synthesis.
A parallel set of siRNA-transfected cells was subjected
to immunofluorescence staining for DENV E antigen and
assessed for the extent of DENV infection. Only 4–6% ofFigure 3 Viability and proliferation of mock and DENV-infected Huh7
transfected with either hnRNP C1/C2-specific siRNA or irrelevant negative c
were collected at 0, 12, 24, 36 and 48 h post-infection and subjected to pro
Results are shown as follows: (A) the percentage viability of mock-infected
number of viable mock-infected cells; and (D) the total number of viable D
independent experiments.control and hnRNP C1/C2 siRNA-transfected cells
expressed detectable DENV E antigen at 12 h post-
infection. However, the number of DENV E antigen-
expressing cells rapidly increased over time following
DENV infection (Figure 5A and B). hnRNP C1/C2
siRNA-transfected cells yielded a lower extent of
DENV infection than control siRNA-transfected cells,
namely 25%, 37% and 73% versus 39%, 56% and 86% of
observed cells showing DENV E expression at 24, 36
and 48 h post-infection, respectively (Figure 5A and B).
This decrease in the proportion of DENV E-positive
cells reflected a consequence of hnRNP C1/C2 knock-
down on DENV infection.cells following hnRNP C1/C2 knockdown. Huh7 cells were
ontrol siRNA followed by mock or DENV infection at MOI 0.03. Cells
pidium iodide (PI) staining and trypan blue exclusion dye assay.
cells; (B) the percentage viability of DENV-infected cells; (C) the total
ENV-infected cells. Data represent mean and SEM of three
Figure 4 Effect of hnRNP C1/C2 knockdown on DENV RNA
synthesis. Huh7 cells transfected with hnRNP C1/C2-specific or
control siRNA were infected with DENV at MOI 0.03. Cells were
collected at 0, 12, 24, 36 and 48 h post-infection and subjected to
total RNA extraction and subsequent reverse transcription and
real-time PCR for determination of DENV RNA expression. The amount
of DENV RNA in virus-infected cells was reported as viral RNA copies
per cell. Data represent mean and SEM of three independent
experiments. Asterisks indicate statistically significant differences
(*p < 0.05) in DENV viral RNA levels between the specific siRNA-transfected
and control siRNA-transfected groups by unpaired t test.
Dechtawewat et al. Virology Journal  (2015) 12:14 Page 6 of 14Further analysis of DENV NS1 and E protein levels in
control and hnRNP C1/C2 siRNA-transfected cells using
immunoblotting showed that both DENV protein bands
were initially visible at 24 h post-infection, and their
expression increased over time in both the siRNA-
transfected samples after DENV infection (Figure 6A).
The intensity of the DENV NS1 and E protein bands
was lower in hnRNP C1/C2 siRNA-transfected cells (SP)
than the control cells (IR) at all time points (Figure 6A).
After normalization with β-actin (internal control), rela-
tive levels of DENV NS1 and E protein expression in
hnRNP C1/C2 siRNA-transfected cells decreased by 20–
40% and 30–50%, respectively, compared with the con-
trol cells at 24–48 h post-infection (Figure 6B). At 48 h
post infection, although relative levels of DENV NS1
and E protein expression in hnRNP C1/C2 siRNA-
transfected cells were significant different from that in
the control cells (Figure 6); the percentage of DENV E
antigen-expressing cells transfected with either siRNA
did not show statistically significant difference (Figure 5).
This implied that hnRNP C1/C2 knockdown may have
no significant impact on the number of DENV-infected
cells when encountering multiple rounds of virus repli-
cation, but it could still decrease the extent of viral pro-
tein expression significantly. Altogether, our findings
based on real-time RT-PCR, immunofluorescence stain-
ing and immunoblotting analysis suggested that hnRNPC1/C2 knockdown had effects on viral RNA and protein
syntheses during DENV replication.
To further investigate whether the effect of hnRNP
C1/C2 knockdown on viral protein synthesis is due to
direct inhibition of DENV translation, control and hnRNP
C1/C2 siRNA-transfected cells were co-transfected with
DENV reporter RNA and internal control reporter RNA.
In parallel, DENV reporter RNA-transfected cells that
were treated with DENV capsid-specific siRNA to knock-
down DENV reporter RNA template used for viral trans-
lation or with cycloheximide to inhibit overall protein
translation served as positive controls for inhibition of
protein translation. Firefly and Renilla luciferase activities
were measured at 12 h after reporter RNA transfection
and relative luciferase expression was specifically indica-
tive of DENV protein translation. In addition, immuno-
blotting analysis was performed to confirm the levels of
hnRNP C1/C2 and β-actin expression in the same set of
samples. As expected, DENV reporter RNA knockdown
cells showed approximately 60% specific inhibition of viral
protein translation (Figure 7A) and expressed similar
levels of hnRNP C1/C2 and β-actin proteins, compared
with non-treated cells (Figure 7B, NT and RK). Treatment
with cycloheximide appeared to reduce both viral and host
protein translation in our assay as decreased levels of both
firefly and Renilla luciferase activities were observed (data
not shown) and, therefore, no specific inhibition of viral
protein translation was detected in cycloheximide-treated
cells when compared with non-treated cells (Figure 7A). A
marked reduction of hnRNP C1/C2 and β-actin expres-
sion observed in the same sample also confirmed this no-
tion (Figure 7B, CHX compared with NT). In contrast to
these positive controls, transfection with hnRNP C1/C2-
specific siRNA did not result in specific inhibition of viral
protein translation (Figure 7A) since levels of both firefly
and Renilla luciferase activities remained unchanged (data
not shown), despite a specific decrease in hnRNP C1/C2
protein expression detected (Figure 7B, SP), when com-
pared to control siRNA transfection (Figure 7A and B, IR).
These findings implied that hnRNP C1/C2 knockdown
had no direct influence on DENV protein translation.
Effect of hnRNP C1/C2 knockdown on infectious DENV
production
Further study was carried out to examine whether
hnRNP C1/C2 knockdown affected the production of in-
fectious DENV. Supernatants from control and hnRNP
C1/C2 siRNA-transfected cell cultures were collected
and assessed for infectious virus titers by FFU assay.
Extracellular infectious DENV was detectable at low
levels (<10 FFU/ml) in culture supernatants collected at
12 h post-infection from control and hnRNP C1/C2
siRNA-transfected cultures, and increased continuously
thereafter in both cultures (Figure 8). However, DENV
Figure 5 Effect of hnRNP C1/C2 knockdown on the extent of DENV infection. Huh7 cells transfected with hnRNP C1/C2-specific siRNA or
control siRNA were infected with DENV at MOI 0.03 or left uninfected (mock control). The cells were collected at 12, 24, 36 and 48 h post-infection and
subjected to immunofluorescence staining for DENV E antigen. The extent of DENV infection was determined based on the enumerated numbers of DENV
E antigen-positive cells. (A) Representative images of immunofluorescently stained cells from three independent experiments. Images of mock-infected
cells at 24 h post-infection and DENV-infected cells at 12, 24, 36 and 48 h post-infection are shown. Dengue E antigen (green); nucleus (blue); magnification
(63×). (B) Percentage infection is shown as mean and SEM of three independent experiments. Asterisks indicate statistically significant differences
(**p < 0.01) in the percentage DENV infection between the specific siRNA-transfected and control siRNA-transfected groups by unpaired t test.
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were significantly lower than in the control siRNA-
transfected culture by 3–4 fold at 24–48 h post-infection.
A reduction of infectious DENV production in the cul-
tures following specific siRNA transfection confirmed
the interference of hnRNP C1/C2 knockdown on DENV
replication.
Discussion
hnRNP C1/C2 are RNA-binding host cellular proteins
that play important roles in replication of certain positive-strand RNA viruses such as poliovirus and hepatitis C
virus (HCV) [30-33]. Nevertheless, their functional contri-
bution to DENV replication remains largely unexplored.
The present study used an in vitro model of Huh7 cells
for DENV infection and specific siRNA-mediated gene
knockdown to investigate the potential involvement of
hnRNP C1/C2 in the process of DENV infection. We
demonstrated an association between hnRNP C1/C2 and
viral RNA in DENV-infected Huh7 cells. A significant
knockdown of hnRNP C1/C2 proteins following specific
siRNA transfection affected DENV infection by decreasing
Figure 6 Effect of hnRNP C1/C2 knockdown on DENV protein expression. Huh7 cells transfected with hnRNP C1/C2-specific siRNA (SP) or
irrelevant negative control siRNA (IR) were infected with DENV at MOI 0.03. Cells were collected at 12, 24, 36 and 48 h post-infection and subjected to
immunoblotting analysis using monoclonal antibodies specific against DENV NS1, DENV E and β-actin (internal control). Three independent experiments
were performed. (A) Protein bands of DENV NS1, DENV E and β-actin in DENV-infected cells transfected with specific siRNA (SP) or control siRNA
(IR). (B) The intensity of DENV NS1 and E bands in both IR and SP samples was first normalized to that of β-actin bands in the same set of
samples. The obtained relative intensity of DENV NS1 and E in the SP samples was then normalized to that in the IR samples. Results show fold
change of relative DENV NS1 and E protein expression in the SP samples compared with the corresponding IR samples. Asterisks indicate statistically
significant differences (*p < 0.05) in DENV NS1 and E protein expression between the specific siRNA-transfected and control siRNA-transfected groups
by unpaired t test.
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quent production of infectious virus.
hnRNP C1/C2 are abundant host cellular proteins
found predominantly in the nucleus, but they can trans-
locate to the cytoplasm under certain conditions [20-25].
Active export of hnRNP C1/C2 to the cytoplasm was
triggered by tumor necrosis factor-α or phorbol 12-
myristate 13-acetate (PMA)-mediated apoptosis through
activation of Rho-associated kinase [22]. The presence of
hnRNP C1/C2 in the cytoplasm was also observed dur-
ing mitosis upon nuclear membrane breakdown in late
G2/M phase of the cell cycle [25]. Additionally, cytoplas-
mic re-localization of hnRNP C1/C2 has been found in
rhinovirus, poliovirus and vesicular stomatitis virus infec-
tions, through inhibition of nuclear import and changes
in the composition of nuclear pore complexes [21,23] or
enhanced nuclear export of the proteins [24]. A previ-
ous study of DENV infection demonstrated the pres-
ence of hnRNP C1/C2 predominantly in the nuclear
fraction, and to a lesser degree in the cytoplasmic frac-
tion of virus-infected EA.hy926 cells, using a subcellularfractionation assay [28]. This finding was consistent
with the detection of hnRNP C1/C2 in the cytoplasm by
immunofluorescence staining in DENV-infected HEK
293T cells [26] and DENV-infected Huh7 cells (data not
shown). However, no difference in the pattern of subcellu-
lar localization of hnRNP C1/C2 between mock-infected
and DENV-infected cells was observed [26].
Specific siRNA transfection resulted in a significant
decrease in hnRNP C1/C2 at both mRNA and protein
levels (Figure 2A and B). As demonstrated by immuno-
fluorescence staining of DENV E antigen, the hnRNP
C1/C2 knockdown reduced the percentage of cells ex-
pressing this viral protein (Figure 5). This effect was un-
likely due to a direct hindrance at the initial step of DENV
binding and entry into the cells, because hnRNP C1/C2
were undetectable on the cell surface (data not shown).
Rather, it probably resulted from multiple downstream
processes within the DENV replication cycle that led to a
signification decrease in DENV production (Figure 8).
Using real-time RT-PCR, delayed kinetics of viral RNA
synthesis were observed in DENV-infected cells following
Figure 8 Effect of hnRNP C1/C2 knockdown on release of
infectious DENV. Huh7 cells transfected with hnRNP C1/C2-specific
siRNA or control siRNA were infected with DENV at MOI 0.03. Supernatant
from DENV-infected culture was collected at 0, 12, 24, 36 and 48 h
post-infection and assessed for titers of infectious DENV by FFU assay.
Results are derived from three independent experiments. Asterisks
indicate statistically significant differences (**p < 0.01; ***p < 0.005)
in DENV titers between the specific siRNA-transfected and control
siRNA-transfected groups by unpaired t test.
Figure 7 Effect of hnRNP C1/C2 knockdown on DENV protein
translation. Huh7 cells transfected with hnRNP C1/C2-specific siRNA
(SP) or irrelevant negative control siRNA (IR) were subjected to
co-transfection with pGL3-DENV2-5′UTR-72ntC-Fluc-3′UTR construct
(viral reporter) and pRL-SV40 construct (internal control reporter). At
12 h after reporter RNA transfection, cells were harvested and
assessed for firefly and Renilla luciferase activities. In parallel, reporter
RNA-transfected cells that were treated with DENV capsid-specific siRNA
to knockdown viral reporter RNA template used for viral translation (RK)
or with cycloheximide to inhibit overall protein translation (CHK) were
set up as positive controls in this assay for inhibition of protein
translation, compared with non-treated cells (NT). (A) Relative luciferase
expression specifically indicated DENV protein translation. In each
sample, relative luminescence units of firefly luciferase activity were
normalized to that of Renilla luciferase activity. Normalized luciferase
signals of control siRNA-transfected cells and non-treated cells were set
to 1. Relative luciferase expression in hnRNP C1/C2-specific siRNA was
compared to that in control siRNA-transfected cells whereas relative
luciferase expression in viral reporter knockdown cells and cycloheximide-
treated cells was compared to that in non-treated cells. Data represent
mean and SEM of three independent experiments. Asterisks indicate
statistically significant difference (***p < 0.0001) in relative luciferase
expression between viral reporter knockdown cells and non-treated
cells by unpaired t test. (B) Immunoblotting analysis was performed
to confirm the expression of hnRNP C1/C2 and β-actin proteins in each
sample. Results are representative of three independent experiments
with similar outcome.
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reduction of viral RNA accumulation at 36 h post-
infection (Figure 4). This suggested a potential contri-
bution of hnRNP C1/C2, in association with viral RNA,
to facilitate the RNA replication process of DENV. Simi-
lar findings on the role of hnRNP C1/C2 in virus repli-
cation have been reported in other positive-strand RNA
viruses such as poliovirus and HCV [30-33]. hnRNP C1/C2have been shown to interact with 5′- and 3′-ends of
poliovirus negative-strand RNA intermediate and with
poliovirus protein precursors, which are essential for
virus replication; that is, 3CD (a precursor of viral
RNA-dependent RNA polymerase), P2 and P3 (precur-
sors of nonstructural proteins), hence promoting viral
replication complex assembly and viral RNA synthesis
of poliovirus [31-33]. Moreover, hnRNP C1/C2, accom-
panied by polypyrimidine-tract binding protein (PTB or
hnRNP I), bind to the pyrimidine-rich region within the
3′-untranslated region (UTR) of HCV RNA and initiate
and/or regulate HCV replication [30]. The detailed
mechanism whereby hnRNP C1/C2 associate with viral
RNA in DENV-infected cells is not known. It might be
that this interaction functions, in concert with other viral
and host proteins, to assist the structural formation of the
viral replication complex required for DENV replication.
hnRNP C1/C2 have previously been found to interact
with vimentin and viral NS1 in DENV-infected cells and
disruption of vimentin results in reduced cell-associated
DENV NS1 expression and DENV production [28]. In
support of these findings, the present study revealed that
hnRNP C1/C2 knockdown diminished the expression
of DENV NS1 and E proteins in DENV-infected cells
(Figure 6). Whether the hnRNP C1/C2 knockdown
may alter the presence of vimentin in the intracellular
milieu is of interest but has not been assessed in our
study. It was possible that hnRNP C1/C2 proteins may
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protein expression. Previous studies have demon-
strated that binding of hnRNP C1/C2 with 3′-UTR of
amyloid precursor protein mRNA and urokinase re-
ceptor mRNA increase the stability of mRNAs [34,35].
Furthermore, hnRNP C1/C2 function as translational
modulators to regulate protein expression, most likely
through their specific binding to polyuridine-rich regions
of RNA, some of which may have internal ribosome entry
site (IRES) activity [14]. Interactions of hnRNP C1/C2
with IRES of c-myc mRNA, c-cis mRNA, upstream of N-
Ras (UNR) mRNA and X-linked inhibitor of apoptosis
(XIAP) mRNA stimulate IRES-mediated translation, thus
resulting in increased protein expression [25,36-38]. Un-
like poliovirus and HCV, 5′-UTR of DENV genome does
not possess IRES activity, and translation of DENV occurs
by non-IRES-mediated mechanisms through canonical
cap-dependent and noncanonical cap-independent pro-
cesses [39]. In our study, knockdown of hnRNP C1/C2
did not show a direct effect on DENV protein translation
as demonstrated by the DENV luciferase reporter assay
(Figure 7A and B). As a consequence, the reduced viral
protein expression following knockdown of hnRNP
C1/C2 observed in this study likely resulted from a re-
duction of viral RNA templates generated during
DENV replication rather than direct influence on viral
translation.
Following viral RNA replication and protein transla-
tion, assembly of DENV particles occurs in the ER. Im-
mature viruses are subsequently transported along the
secretory pathway to the trans-Golgi network for further
modification, before release into the extracellular milieu
[9,40]. In our study, determination of DENV titers in the
culture supernatant demonstrated a significant reduction
of infectious virus production from DENV-infected cells
upon hnRNP C1/C2 knockdown (Figure 8). This may
have been the consequence of decreased levels of viral
RNA and protein syntheses in DENV-infected knock-
down cells. The suppressive effects of hnRNP C1/C2
knockdown on viral RNA replication and protein ex-
pression and infectious virus production were unlikely
to have resulted from induction of cell death and inhib-
ition of cell proliferation owing to hnRNP C1/C2 knock-
down. No significant differences in cell viability and total
numbers of cells were observed between control siRNA
and hnRNP C1/C2-specific siRNA transfection (Figure 3).
However, it should be noted that the total number of
hnRNP C1/C2 knockdown cells seemed to be slightly
lower than that of control cells at 48 h post-infection.
These observations were in line with a previous report in
HEK 293T cells showing that hnRNP C1/C2 knockdown
did not enhance cell death but affected cell growth at 72
and 96 h post-culture, by impairment of cell cycle progres-
sion and accumulation of cells in the G2/M phase [37].Therefore, it is possible that the consequences of hnRNP
C1/C2 knockdown on the process of DENV replication
may occur through direct interaction of hnRNP C1/C2
with DENV RNA and/or through their effects on other
cellular activities. The role of hnRNP C1/C2 in DENV
replication deserves further investigation to explore mo-
lecular mechanisms in detail. Future study may also be
extended to other types of target cells, such as monocytes
and macrophages in primary infection and antibody-
dependent enhancement condition, to assess whether
hnRNP C1/C2 have any effect on host cellular response to
DENV infection.
Conclusions
The present study using DENV-infected Huh7 cells in
the presence of siRNA-specific gene knockdown demon-
strated hnRNP C1/C2 association with viral RNA and a
potential important role of the hnRNP C1/C2 in sup-
porting DENV replication, most likely at the stage of
viral RNA synthesis. Our findings pave the way for fur-
ther study on the molecular mechanisms of the viral and
host protein interactions required for viral replication in
DENV-infected cells.
Materials and methods
Cell lines, virus, and antibodies
Human hepatocellular carcinoma (Huh7) cells were ob-
tained from JCRB Cell Bank (Osaka, Japan) and cultured
in RPMI 1640 (Gibco, Carlsbad, CA, USA) supplemented
with 10% heat-inactivated fetal bovine serum (FBS; Gibco),
2 mM L-glutamine (Sigma, St. Louis, MO, USA), 1% non-
essential amino acid (NEAA; Gibco), 37 μg/ml penicillin
(Sigma) and 60 μg/ml streptomycin (Sigma) at 37°C in a
5% CO2 incubator with a humidified atmosphere. Propa-
gation of DENV serotype 2 (strain 16681) was performed
in C6/36 mosquito cells. Mouse monoclonal antibodies
specific for DENV NS1 (clone NS1-3 F.1) and DENV E
(clones 3H5 and 4G2) were produced from previously
established hybridoma cells [41-43]. Mouse monoclonal
antibodies specific for human hnRNP C1/C2 (clone 4 F4)
and human β-actin (clone C4) were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). Mouse
isotype-matched control IgG1 antibody (clone MOPC 21)
was purchased from Sigma.
Immunoprecipitation of hnRNP C1/C2 proteins
Huh7 cells (5 × 106) were seeded into a T-75 cm2 flask
(Costar, Cambridge, MA, USA) and cultured for 24 h.
The adherent cells were incubated with DENV-2 at a
multiplicity of infection (MOI) of 0.5 in the culture
medium at 37°C in a 5% CO2 incubator for 2 h. The
supernatant containing DENV was discarded and the cul-
ture was maintained in fresh medium under the condi-
tions described above. At 48 h post-infection, uninfected
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harvested and clear lysates were prepared by resuspending
cell pellets with RIPA buffer containing 20 mM Tris–HCl,
pH 7.4, 5 mM EDTA, 150 mM NaCl, 1% Triton X-100,
0.1% SDS, and 0.5% deoxycholate with protease inhibitor
cocktail (Roche, Mannheim, Germany), then incubated on
ice for 30 min and centrifuged at 9100 g at 4°C for 5 min.
The clear lysates were subjected to immunoprecipitation
by incubating with 5 μg mouse isotype-matched control
IgG1 antibody or mouse anti-hnRNP C1/C2 antibody
(clone 4 F4, IgG1) at 4°C overnight. Thereafter, the sam-
ples were incubated with 50% slurry protein-G-conjugated
sepharose 4B beads (GE Healthcare, Uppsala, Sweden) at
4°C for 2 h followed by centrifugation at 15,300 g at 4°C
for 5 min, and three washes with RIPA buffer. The immu-
noprecipitated complexes were eluted with nonreducing
buffer and subjected to immunoblotting analysis to deter-
mine the presence of hnRNP C1/C2 proteins. Alterna-
tively, the immunoprecipitated complexes on the beads
were directly processed for RNA extraction and subse-
quent reverse transcriptase polymerase chain reaction
(RT-PCR) for determination of DENV RNA.
siRNA-mediated knockdown of hnRNP C1/C2
Huh7 cells were seeded onto a 24-well plate in medium
without antibiotics (maintenance medium) at a concen-
tration of 9 × 104 cells/well. Fifteen hours later when the
cells reached ~50% confluence, the medium was replaced
with fresh RPMI medium and the cells were transfected
with duplex hnRNP C1/C2-specific siRNA (siGENOME
SMARTpool Human HNRNPC M-011869-01; Dharmacon,
Lafayette, CO, USA) or duplex irrelevant siRNA (Stealth
RNAi negative control medium GC; Invitrogen, Carlsbad,
CA, USA), which is designed to minimize sequence hom-
ology to any known vertebrate transcript, using Lipofecta-
mine 2000 (Invitrogen) according to the manufacturer’s
instructions. After 6 h incubation with siRNA (114 nM),
the cells were supplemented with maintenance medium
and incubated for a further 18 h. The second round of
siRNA transfection was performed using a similar ap-
proach to that described above. To test the effects of
hnRNP C1/C2 knockdown on DENV infection, cells that
had been subjected to the second round of siRNA trans-
fection for 6 h were incubated with DENV-2 at MOI 0.03
or maintenance medium (mock control) for 2 h. The cells
were washed twice and cultured in maintenance medium.
The time interval between initial transfection and DENV
infection was 32 h. At 0, 12, 24, 36 and 48 h post-
infection, mock-infected and DENV-infected cells and
their culture supernatants were collected. The total
number of viable cells was enumerated using trypan
blue (Gibco) exclusion dye assay. The percentage of
dead cells was assessed by staining with propidium iod-
ide (PI) at a final concentration of 2 ng/μl for 15 min at4°C and subsequent flow cytometric analysis. Aliquots
of the cells were processed for immunoblotting analysis,
real-time RT-PCR, and immunofluorescence staining,
and the culture supernatants were subjected to a focus
forming unit (FFU) assay as described below.
Immunoblotting analysis
Clear lysates or immunoprecipitated samples prepared
from mock-infected and DENV-infected cells that were
untransfected or transfected with siRNA were mixed with
4× loading buffer [50 mM Tris–HCl (pH 6.8), 2% SDS,
0.1% bromophenol blue and 10% glycerol] with or without
5% β-mercaptoethanol and heated at 95°C for 5 min. Pro-
teins in the samples were subjected to 10% SDS-PAGE
and transferred to PVDF membranes (Millipore, Billerica,
MA, USA) as previously described [26]. The membranes
were incubated with 5% skim milk in PBS or in Tris-
buffered saline with 0.05% Tween 20 (TBST) for 1 h to
block nonspecific binding and then with mouse mono-
clonal antibodies specific for DENV NS1 (clone NS1-3 F.1),
DENV E (clone 4G2), human hnRNP C1/C2 (clone 4 F4)
and human β-actin (clone C4) at 4°C overnight. The
membranes were washed three times with PBS or TBST
and incubated with HRP-conjugated rabbit anti-mouse
immunoglobulin antibody (DAKO) at a dilution of 1:1000
for 1 h at room temperature, followed by a further three
washes. Immunoreactive proteins were visualized using an
enhanced chemiluminescence detection kit (Western
Lightning Chemiluminescence Reagent Plus; Perkin Elmer
Applied Biosystems, Foster City, CA, USA). Relative levels
of human hnRNP C1/C2, DENV NS1 and DENV E pro-
tein expression were assessed by normalization of their
protein band intensities to human β-actin intensity using
GeneTools software from Syngene (Cambridge, UK).
Determination of DENV RNA in immunoprecipitated
complexes
RNA was extracted from immunoprecipitated complexes
captured on protein G sepharose beads by TRIzol re-
agent (Invitrogen) and subjected to reverse transcription
using SuperScript III Reverse Transcriptase (Invitrogen)
according to the manufacturer’s protocol, with the NS1-R
primer (Table 1). The resultant cDNA was used as a
template for amplification of DENV NS1 region with
the NS1-F and NS1-R primers (Table 1) using Biometra
TGradient Thermal Cycler (Biometra GmbH, Goettingen,
Germany). A 25-μl reaction contained cDNA template, 1×
Green GoTaq Flexi Reaction Buffer (Promega, Madison,
WI, USA), 2.5 mM MgCl2, 0.2 mM dNTPs, and 0.4 μM
primers NS1-F and NS1-R, 0.5 U Taq DNA polymerase
(Promega) in deionized water. The PCR reaction was pre-
heated at 94°C for 5 min and processed through 35 cycles
of denaturation (94°C, 30 s), annealing (48°C, 30 s) and ex-
tension (72°C, 1 min 30 s), as well as a final extension at
Table 1 Oligonucleotide primers for reverse transcription-PCR
Primer Orientation Sequence
NS1-F Sense 5′ CCGGCCAGATCTGATAGTGGTTGCGTTGTGAGC 3′
NS1-R Antisense 5′ GATCGATCGCGGCCGCTTAGGCTGTGACCAAGG AGTTAACCAAATTCTCTTCTTTCTC 3′
hnRNP C1/C2-F Sense 5′ TCGAAACGTCAGCGTGTATC 3′
hnRNP C1/C2-R Antisense 5′ TCCAGGTTTTCCAGGAGAGA 3′
DEUR Antisense 5′ GCTGTGTCACCCAGAATGGCCAT 3′
D2L Sense 5′ ATCCAGATGTCATCAGGAAAC 3′
D2R Antisense 5′ CCGGCTCTACTCCTATGATG 3′
actin-F Sense 5′ AGAAAATCTGGCACCACAAA 3′
actin-R Antisense 5′ CTCCTTAATGCTACGCACGA 3′
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in 1.5% SeaKem LE Agarose gel (Cambrex Bio Science;
Rockland, ME, USA) and visualized by Gene Genius Bio
Imaging system (Syngene).
Real-time RT-PCR for measurement of hnRNP C1/C2
mRNA and DENV RNA
RNA was extracted from DENV-infected cells that were
transfected with irrelevant siRNA or hnRNP C1/C2-
specific siRNA by TRIzol reagent (Invitrogen). Reverse
transcription was performed using 62.5 ng total RNA and
SuperScript III Reverse Transcriptase (Invitrogen) or AMV
Reverse Transcriptase (Promega), according to the manu-
facturer’s instructions with minor modifications. Oligo(dT)
20 primer and DEUR primer (Table 1) were used to
synthesize cDNA templates for determination of human
hnRNP C1/C2 and β-actin mRNA as well as DENV RNA,
respectively. The resultant cDNA was used as a template
for real-time PCR according to the manufacturer’s instruc-
tions for Light Cycler 480 SYBR Green I master mix
(Roche, Mannheim, Germany), using primer pairs specific
for human hnRNP C1/C2 and β-actin as well as DENV E
(D2L and D2R) (Table 1). Real-time PCR was performed
by LightCycler 480 II (Roche) with: (i) pre-incubation at
95°C for 10 min; (ii) 45 amplification cycles of denaturation
at 95°C for 10 s, annealing at 62°C for 10 s, and extension
at 72°C for 20 s; and (iii) melting curve and cooling steps
as recommended by the manufacturer. Relative levels of
human hnRNP C1/C2 mRNA expression were determined
by normalization to the expression levels of human actin
according to the 2–ΔΔCt method [44]. Standard DENV
RNA with known concentration (copy number/μl) that
was subjected to the same reverse transcription and real-
time PCR processes was used as a control for determining
the amount of viral RNA in DENV-infected cells.
Immunofluorescence staining for the detection of DENV E
antigen
To determine the percentage of DENV infection, mock-
infected and DENV-infected cells that were transfectedwith irrelevant siRNA or hnRNP C1/C2-specific siRNA
were fixed with 4% paraformaldehyde in PBS, smeared
on a glass slide, and left to air dry for 30 min at room
temperature. The cells were permeabilized with 0.2%
Triton X-100 for 10 min at room temperature and incu-
bated successively with mouse anti-DENV E monoclonal
antibody (clone 3H5) for 1 h at room temperature and
Alexa-Fluor-488-conjugated goat anti-mouse IgG anti-
body (Invitrogen) at a dilution of 1:1,000 for 30 min at
room temperature. The stained cells were visualized by a
confocal laser-scanning microscope (LSM 510 Meta, Carl
Zeiss, Jena, Germany).
Viral translation assay
A DENV-2 reporter construct was generated by cloning
T7 promoter, DENV-2 5′-UTR, the first 72 nucleotides
of DENV-2 capsid-coding sequence, firefly luciferase
gene and DENV-2 3′-UTR into pGL3-Basic (Promega)
according to a previously described method [45]. Result-
ant viral reporter construct (namely pGL3-DENV2-5′
UTR-72ntC-Fluc-3′UTR) and pRL-SV40 vector (Promega),
which contains Renilla luciferase gene and serves an in-
ternal control reporter construct, were linearized with
XbaI. One μg of purified DNA was subjected to in vitro
transcription using the RiboMAX Large Scale RNA Pro-
duction System-T7 (Promega) in the presence of 20 mM
m7G(5′)ppp(5′)G RNA cap structure analog (New England
BioLabs, Ipswich, MA, USA) and resultant RNA product
was purified using RNeasy Mini Kit (QIAGEN, Hilden,
Germany). To determine the effect of hnRNP C1/C2
knockdown on DENV translation, Huh7 cells were trans-
fected twice with hnRNP C1/C2-specific siRNA or control
siRNA (286 nM each) in a 96-well plate within a 24-h
interval using Lipofectamine RNAiMAX (Invitrogen)
according to the manufacturer’s instructions. After the
second round of siRNA transfection, cells were co-
transfected with 21 nM DENV reporter RNA and 2.1
nM control reporter RNA using Lipofectamine 2000
(Invitrogen) followed by replacement with fresh culture
medium at 4 h later. Following 12 h after transfection
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vested and determined for firefly and Renilla luciferase
expression using Dual-Luciferase Reporter Assay System
(Promega). Both firefly and Renilla luciferase signals were
measured by Synergy H1 Hybrid multi-mode microplate
reader (BioTek, Winooski, VT, USA). Cells that had been
similarly processed in the absence of reporter RNA served
as background controls for luciferase assay. Additionally,
reporter RNA-transfected cells that were treated with
286 nM DENV capsid-specific siRNA known to reduce
the production of viral protein and infectious virus [46]
or with 50 μM cycloheximide, an inhibitor of protein
translation, were included in the assay to serve as posi-
tive controls for inhibition of protein translation.
Focus forming unit (FFU) assay for the determination of
DENV production
Supernatants collected from cultured DENV-infected cells
that had been transfected with irrelevant siRNA or hnRNP
C1/C2-specific siRNA were assessed for the production of
infectious DENV. Vero cells were seeded onto a 96-well
plate (Costar) at 2.5 × 104 cells/well in minimal essential
medium (MEM) supplemented with 10% FBS, 2 mM L-
glutamine, 36 μg/ml penicillin and 60 μg/ml streptomycin,
and cultured at 37°C in a 5% CO2 incubator for 24 h to
obtain ~90% confluence of the cell monolayer. The
medium was removed from each well. DENV was serially
diluted 10-fold in MEM containing 3% FBS, 2 mM L-
glutamine, 36 μg/ml penicillin and 60 μg/ml streptomycin,
added to each well (100 μl/well) and incubated at 37°C in
a 5% CO2 incubator for 2 h. Overlay medium (MEM con-
taining 3% FBS, 10% tryptose phosphate broth and 1.5%
gum tragacanth) was added to each well (100 μl/well), and
the culture was incubated for a further 3 days under the
same conditions. On the third day post-infection, the
medium was discarded from DENV-infected cells and the
adherent cells were washed three times with PBS (pH 7.4).
The cells were fixed with 3.7% formaldehyde (BDH Labora-
tory Supplies, Poole, UK) in PBS at room temperature for
10 min followed by an additional 10 min of permeabilization
with 1% Triton X-100 (Fluka, Steinheim, Switzerland).
The cells were incubated sequentially with mouse anti-
DENV E monoclonal antibody (clone 4G2) at room
temperature for 1 h and HRP-conjugated rabbit anti-
mouse Igs (DAKO) at a dilution of 1:500 in PBS contain-
ing 2% FBS and 0.05% Tween-20 in the dark at room
temperature for 30 min. To develop an enzymatic reac-
tion, the cells were incubated with a substrate solution
containing 0.6 mg/ml diaminobenzidine (DAB), 0.03%
H2O2 and 0.08% NiCl2 in PBS at room temperature in the
dark for 5 min. After three washes with PBS, dark brown
foci of the DENV-infected cells were counted under a
light microscope. Virus titers were reported as FFU/ml
from the duplicated samples.Statistical analysis
Relative levels of hnRNP C1/C2 mRNA and protein ex-
pression, cell viability, cell proliferation, percentage DENV
infection, amount of DENV RNA, relative levels of DENV
NS1 and E proteins, relative luciferase expression, and
titers of infectious DENV were statistically analyzed by
unpaired t test, with the use of GraphPad Prism version
5.0. Results were expressed as mean and standard error
of the mean (SEM) and p < 0.05 was considered significant.
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